BrickBio
ApprovedBrickBio: Bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins
Founded
2019
Focus
Biologics
About
BrickBio: Bioconjugation platform for site-specific, site-selective modification of antibodies and other proteins
Funding History
2Total raised: $53.5M
Series A$45MDigitalis VenturesOct 15, 2023
Seed$8.5MDigitalis VenturesJan 15, 2022
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile